Altered natural killer cell differentiation in CD34+ progenitors from Chronic Myeloid Leukemia patients
- 25 May 2000
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 19 (23) , 2758-2766
- https://doi.org/10.1038/sj.onc.1203584
Abstract
IL-15 and SCF fail to induce NK differentiation and proliferation of CD34+ hematopoietic progenitors from chronic myeloid leukemia patients in contrast to normal stem cells although, both normal and leukemic CD34+ cells display comparable expression of c-kit or IL-15 receptor subunits. Interestingly, confocal microscopy analysis revealed that leukemic and most normal CD34+ cells produce and secrete IL-15, as shown by its trafficking through the Golgi apparatus and early endosomes. However, only leukemic progenitors express the membrane bound IL-15. Colocalization and internalization of IL-15Rβ/γc and IL-15Rα/γc complexes indicated that IL-15 was specifically uptaken by leukemic progenitors. We also demonstrated that in both normal and leukemic progenitors, the signaling kinase Jak3 is constitutively pre-associated with the γc chain. Anti-IL-15 neutralizing mAb treatment resulted in down-regulation of γc chain and disruption of γc/Jak3 interaction in normal but had no effect in leukemic progenitors. Our results suggest the existence in both normal and leukemic CD34+ cells of a constitutive production of a bioactive IL-15 that does not lead to NK differentiation and further indicate that membrane bound IL-15 and constitutive activation of γc are hallmarks of leukemic progenitors.Keywords
This publication has 26 references indexed in Scilit:
- Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemiaJournal of Clinical Investigation, 2000
- IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loopsOncogene, 1998
- A requirement for NF-kappa B activation in Bcr-Abl-mediated transformationGenes & Development, 1998
- Privatization and agrarian reform in the and Caucasian economies∗Central Asian Survey, 1997
- A potential role for interleukin-15 in the regulation of human natural killer cell survival.Journal of Clinical Investigation, 1997
- The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15Immunity, 1995
- Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.The Journal of Experimental Medicine, 1994
- Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 ReceptorScience, 1994
- Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.The Journal of Experimental Medicine, 1990
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990